Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of timing of Creon at meals on fat malabsorption in adult cystic fibrosis patients
2019-004940-31Phase 4Terminated
- Sponsor
- Terese Katzenstein
- Start
- Mar 2020
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pancreatin in cystic fibrosis (CF), intestinal malabsorption and fat malabsorption (2 arms), sponsored by Terese Katzenstein. Primary endpoint: GI pains VAS score. Started Mar 2020; status: terminated.
02
Drugs
pancreatin
03
Conditions
cystic fibrosis (CF)intestinal malabsorptionfat malabsorption
Beyond the preview
Go deeper on 2019-004940-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004940-31.